Saccharin Increases Fasting Blood Glucose but Not Liver Insulin Resistance in Comparison to a High Fructose-Fed Rat Model

Recent data indicate that artificial sweeteners (AS) may have deleterious effects on glucose metabolism. The purpose of this study was to compare the effects of AS and the effects of a high fructose diet (HFrD) on glucose metabolism and insulin resistance (IR) in Sprague-Dawley (SD) rats. SD rats were fed either regular chow, chow with saccharin (Sac) (0.1 mg/mL) placed in their water, or HFrD for seven weeks. Glucose, insulin, and triglycerides (Tg) levels were measured upon completion. A homeostatic model assessment (HOMA)-IR index was used to determine insulin resistance. The liver was stained to detect signs of a fatty liver. Hepatic mRNA expression of glucose metabolism regulation genes, Srepb-1c (sterol regulatory element binding protein) and ChREB (α & β) (carbohydrate response element binding protein), as well as other glycolytic and lipogenic genes including glucose-6-phosphatase (G6pc), were considered IR markers. Both HFrD and Sac significantly increased fasting blood glucose levels compare to the control (140 ± 5 and 137 ± 6 vs. 118 ± 3 mg/dL, respectively, p < 0.05). However, only HFrD increased insulin secretion (0.99 ± 0.12 vs. 0.7 ± 0.1 and 0.6 ± 0.1 ug/L), Tg levels (420 ± 43 vs. 152 ± 20 and 127 ± 13 mg/dL), and the HOMA-IR index (3.4 ± 0.4 vs. 2.3 ± 0.36 and 2.13 ± 0.3) (HFrD vs. control and sac, p < 0.05). Fatty liver changes were only observed in HFrD fed rats. The expression of ChREB β, Srepb-1c, and G6pc mRNA were only significantly elevated (between 2–10 times folds, p < 0.05) in HFrD fed rats. Sac may increase fasting blood glucose but has no effect on liver insulin resistance.

[1]  P. Metrakos,et al.  Non-alcoholic fatty liver disease--a chronic disease of the 21st century , 2018, Journal of biomedical research.

[2]  Michelle Fiander,et al.  Nonnutritive sweeteners and cardiometabolic health: a systematic review and meta-analysis of randomized controlled trials and prospective cohort studies , 2017, Canadian Medical Association Journal.

[3]  Joshua A. Salomon,et al.  Health Effects of Overweight and Obesity in 195 Countries over 25 Years. , 2017, The New England journal of medicine.

[4]  D. Prabhakaran,et al.  20-Year Trend of Cardiovascular Disease Risk Factors , 2017 .

[5]  Y. Ni,et al.  Nonalcoholic Fatty Liver Disease and Insulin Resistance: New Insights and Potential New Treatments , 2017, Nutrients.

[6]  M. Fornage,et al.  Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association , 2017, Circulation.

[7]  Mi-Sung Kim,et al.  ChREBP regulates fructose-induced glucose production independently of insulin signaling. , 2016, The Journal of clinical investigation.

[8]  C. Sirlin,et al.  Association Between Quantity of Liver Fat and Cardiovascular Risk in Patients With Nonalcoholic Fatty Liver Disease Independent of Nonalcoholic Steatohepatitis. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[9]  M. Alkafafy,et al.  Impact of aspartame and saccharin on the rat liver: Biochemical, molecular, and histological approach , 2015, International journal of immunopathology and pharmacology.

[10]  Mats Fredrikson,et al.  Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐up , 2015, Hepatology.

[11]  K. Amin,et al.  Alterations in lipid profile, oxidative stress and hepatic function in rat fed with saccharin and methyl-salicylates. , 2015, International journal of clinical and experimental medicine.

[12]  E. Segal,et al.  Artificial sweeteners induce glucose intolerance by altering the gut microbiota , 2014, Nature.

[13]  O. MacDougald,et al.  Administration of saccharin to neonatal mice influences body composition of adult males and reduces body weight of females. , 2014, Endocrinology.

[14]  S. Swithers Artificial sweeteners produce the counterintuitive effect of inducing metabolic derangements , 2013, Trends in Endocrinology & Metabolism.

[15]  H. Makhlouf,et al.  Predictors of All-Cause Mortality and Liver-Related Mortality in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) , 2013, Digestive Diseases and Sciences.

[16]  I. Samojlik,et al.  The influence of chronic intake of saccharin on rat hepatic and pancreatic function and morphology: gender differences. , 2013, Bosnian journal of basic medical sciences.

[17]  M. Blüher,et al.  A novel ChREBP isoform in adipose tissue regulates systemic glucose metabolism , 2012, Nature.

[18]  L. Schmidt,et al.  Public health: The toxic truth about sugar , 2012, Nature.

[19]  R. Ness-Abramof Replacing caloric beverages with water or diet beverages for weight loss in adults: main results of the Choose Healthy Options Consciously Everyday (CHOICE) randomized clinical trial , 2012 .

[20]  I. Barshack,et al.  Lack of interleukin-1α or interleukin-1β inhibits transformation of steatosis to steatohepatitis and liver fibrosis in hypercholesterolemic mice. , 2011, Journal of hepatology.

[21]  E. Rimm,et al.  Sugar-sweetened and artificially sweetened beverage consumption and risk of type 2 diabetes in men. , 2011, The American journal of clinical nutrition.

[22]  A. Khera,et al.  Forecasting the Future of Cardiovascular Disease in the United States: A Policy Statement From the American Heart Association , 2011, Circulation.

[23]  J. Schwarz,et al.  The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome , 2010, Nature Reviews Gastroenterology &Hepatology.

[24]  D. Jacobs,et al.  Diet Soda Intake and Risk of Incident Metabolic Syndrome and Type 2 Diabetes in the Multi-Ethnic Study of Atherosclerosis (MESA) , 2009, Diabetes Care.

[25]  C. McClain,et al.  Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin. , 2008, Journal of hepatology.

[26]  J. Stevens,et al.  Dietary Intake and the Development of the Metabolic Syndrome: The Atherosclerosis Risk in Communities Study , 2008, Circulation.

[27]  J. Goldstein,et al.  Selective versus total insulin resistance: a pathogenic paradox. , 2008, Cell metabolism.

[28]  G. Link,et al.  Fructose-Induced Fatty Liver Disease: Hepatic Effects of Blood Pressure and Plasma Triglyceride Reduction , 2005, Hypertension.

[29]  G. Marchesini,et al.  Association of nonalcoholic fatty liver disease with insulin resistance. , 1999, The American journal of medicine.